MoonLake Immunotherapeutics Class A Ordinary Shares (NASDAQ: MLTX) last traded at $10.82, up 2.27% on the session. The quote above updates while this page is open; the figures below are drawn from MoonLake Immunotherapeutics Class A Ordinary Shares’s own filings and are restated only when a new one is published.
MoonLake Immunotherapeutics Class A Ordinary Shares trades on NASDAQ under the ticker MLTX. Its market capitalisation is $920.85 million.
Valuation measures for MoonLake Immunotherapeutics Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $920.85M |
|---|---|
| Enterprise value | $588.70M |
| Price / book | 2.15 |
| Beta | 1.46 |
Trailing-twelve-month figures tagged in MoonLake Immunotherapeutics Class A Ordinary Shares's XBRL filings with the SEC.
| Net income (TTM) | -$263.05M |
|---|---|
| EPS (TTM) | -$3.85 |
| Return on equity | -61.43% |
| Cash | $477.90M |
Range and volume for MLTX over the past 52 weeks.
| 52-week high | $23.29 |
|---|---|
| 52-week low | $8.80 |
| Volume | 2.01M |
| Average volume | 1.48M |
| Previous close | $10.58 |
Invest a chosen dollar amount in MoonLake Immunotherapeutics Class A Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MLTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.